SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-23-097309
Filing Date
2023-08-31
Accepted
2023-08-31 17:18:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tm2325029-1_424b3.htm 424B3 502368
2 GRAPHIC lg_nrx-4clr.jpg GRAPHIC 44514
  Complete submission text file 0001104659-23-097309.txt   564412
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-265492 | Film No.: 231229523
SIC: 2834 Pharmaceutical Preparations